# Amgen Inc: Form 8-K, filed May 27, 2025

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2025-05-27
- Accepted by EDGAR: May 23, 2025, 18:55 ET
- Period: 2025-05-23
- Accession: 0000950170-25-077233
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000095017025077233/amgn-20250523.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000095017025077233/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000095017025077233/amgn-20250523.htm

Filed May 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-077233. Last ingested by Listed: Oct 27, 2026, 19:36 ET. No prices; not investment advice.